– TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. – Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). – Platform-agnostic chemistry enables seamless integration across sequencing systems. BOULDER, Colo. — Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology […]
LONDON, UK — Touchlight, a leader in cell-free DNA technology, today announced the expansion of its groundbreaking mbDNA™ platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These innovative constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. […]
SAN DIEGO — The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused […]
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and global leader in metabolomics, announces a strategic partnership with Alamar Biosciences to integrate cutting-edge brain health proteomics into its multiomics portfolio. This collaboration enables comprehensive multiomics analysis from a single blood sample – available only from Nightingale Health. Nightingale Health’s […]
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry Genomics, the Sequel II CNDx system […]
BioPAT® Viamass provides high resolution real-time viable capacitance-based biomass measurement directly in the cell culture, enabling direct inline monitoring of cell growth and advanced, precise analysis Seamless scalability with one biomass monitoring method from small-scale Ambr® experiments through to large-scale single-use Biostat STR® or Biostat® RM runs The BioPAT® Viamass single-use sensor integrated with Ambr® […]
Advanced RNA quantification brings efficiency to assay development PALO ALTO, Calif. – Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings direct counting of RNA to the Countable PCR platform, enabling one-step, bias-free RNA quantification, and delivering the […]
Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market, accelerating growth across its industry-leading Sample technologies portfolio Parse provides Evercode, a highly differentiated instrument-free platform built for analyzing millions and billions of […]
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux, a world leader in the field of in vitro diagnostics, have announced the launch of AmPORE-TB, a Research Use Only* (RUO) solution for the rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore […]
LOS ANGELES — Partillion Bioscience today announced the launch of Developer Kits, a ready foundation for teams using Nanovials to build custom assays and workflows. By pairing Nanovials with validated capture antibodies and standardized reagents, Developer Kits reduce early optimization work so researchers can move faster from concept to functional data. “Our customers are constantly expanding […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
